Recent research involving teams from Penn State, Addis Ababa University, and the University of Cambridge has demonstrated the effectiveness of the Bacillus Calmette-Guérin (BCG) vaccine, traditionally used against human tuberculosis, in significantly reducing the transmission of bovine tuberculosis among cattle. Conducted in Ethiopia, the study showed that vaccinated cattle were not only protected from severe TB but also were about 90% less infectious, offering indirect protection to unvaccinated cattle. This discovery is particularly relevant for regions like Ethiopia, where there are no current control programs for bovine TB, and could greatly reduce economic losses and health risks associated with the disease. Additionally, the findings support the potential for cattle vaccination to alleviate the economic and epidemiological burden of bovine tuberculosis in countries like New Zealand, where the disease remains a persistent challenge despite extensive control efforts.